Results 211 to 220 of about 23,901 (228)

Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

Bone, 2017
Maria Carola Zillikens, Richard Eastell, Stuart H Ralston   +2 more
exaly  

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension

Journal of Bone and Mineral Research, 2018
Steven R Cummings, Richard Eastell, Serge Ferrari   +2 more
exaly  

A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density

Journal of Clinical Endocrinology and Metabolism, 2012
David Kendler, Bo Abrahamsen, Henry Bone
exaly  

Denosumab

Reactions Weekly, 2013
openaire   +1 more source

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies†

Journal of Bone and Mineral Research, 2010
Ian Reid, David Kendler, David Dempster
exaly  

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Supportive Care in Cancer, 2015
Miguel Martin, Yasuhiro Fujiwara, Lawrence I Karsh   +2 more
exaly  

Hypercalcemia after discontinuation of long-term denosumab treatment

Osteoporosis International, 2016
Bente L Langdahl, A Kaal
exaly  

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Osteoporosis International, 2011
Nick Freemantle, D Macarios
exaly  

Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials

Clinical Oral Implants Research, 2016
Gerardo Gómez-Moreno, José Luis Calvo Guirado, José Luis Calvo-Guirado   +2 more
exaly  

Denosumab

Reactions Weekly, 2016
  +4 more sources